Author

J. Tran-Rajau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:virus· 1

Frequent Co-Authors

E. Giraud· 2 shared F. Agou· 2 shared J. Chiaravalli· 2 shared E. O. Partuk· 1 shared E. Simon-Loriere· 1 shared F. Donati· 1 shared F. Lemoine· 1 shared F. Touret· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. Giraud

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

High throughput screening identifies broad-spectrum Coronavirus entry inhibitors

S. Khan, E. O. Partuk, J. Chiaravalli, N. Kozer, K. A. Shurrush, Y. Elbaz-Alon, N. Scher, E. Giraud, J. Tran-Rajau, F. Agou, H. M. Barr, O. Avinoam

This study uses high-throughput screening to identify small molecule inhibitors that block coronavirus entry, finding a novel broad-spectrum antiviral.

bioRxiv · Dec 4, 2023Microbiology

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 Omicron sub-lineages

F. Touret, E. Giraud, J. Bourret, F. Donati, J. Tran-Rajau, J. Chiaravalli, F. Lemoine, F. Agou, E. Simon-Loriere, S. Van Der Werf, X. de Lamballerie

This study evaluates the neutralizing activity of monoclonal antibodies against SARS-CoV-2 Omicron sub-lineages and finds reduced efficacy against several variants.

bioRxiv · Dec 22, 2022Microbiology